[Laparoscopic and open subtotal colectomy for inflammatory bowel disease]

Area of Science:

• Gastroenterology
• Surgical Oncology
• Minimally Invasive Surgery

Context:

• Inflammatory Bowel Disease (IBD) management often requires colectomy.
• Surgical options include traditional open colectomy and minimally invasive laparoscopic colectomy (LC).
• Assessing the comparative safety and efficacy of LC versus open colectomy is crucial for IBD treatment.

Purpose:

• To evaluate the safety and efficacy of laparoscopic colectomy (LC) compared to open colectomy for patients with inflammatory bowel disease (IBD).
• To detail the short-term and long-term clinical outcomes and benefits associated with LC in IBD surgery.
• To analyze the cost-effectiveness of LC for IBD treatment.

Summary:

• Laparoscopic colectomy (LC) demonstrates equivalent safety to open colectomy in IBD patients.
• Short-term benefits of LC include accelerated recovery, diminished pain, shorter hospital stays, and reduced complication rates.
• Long-term advantages encompass improved cosmetic outcomes, fewer intra-abdominal adhesions, decreased hospitalizations for small bowel obstruction, and a lower incidence of incisional hernias.

Impact:

• Laparoscopic colectomy presents a viable and advantageous surgical option for IBD management.
• The findings support the broader adoption of LC, potentially improving patient recovery and long-term quality of life.
• Cost-benefit analyses indicate a favorable economic profile for laparoscopic surgery in the context of IBD.